AdobeStock_212764468

Working party guideline/algorithm

Identifying and managing allergic rhinitis in the asthma population

2020-08-23T04:00:00+01:00By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

AdobeStock_142414773

Independent professional body guideline

BTS/SIGN asthma in pregnancy guideline

2020-08-20T13:08:00+01:00By

This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers

An inhaler in WPG Yellow

Working party guideline/algorithm

Inhaler choice guideline

2020-07-31T08:50:00+01:00By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.

doctor writing

Independent professional body guideline

GINA strategy 2020: assessing patients with asthma

2020-07-20T13:25:00+01:00By

This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.

doctor writing notes holding inhaler

Independent professional body guideline

GINA strategy 2020: asthma–COPD overlap

2020-07-20T13:24:00+01:00By

This Guidelines summary outlines recommendations for the diagnosis and initial treatment of adults with features of asthma, chronic obstructive pulmonary disease (COPD), or both. 

doctor with inhalers

Independent professional body guideline

GINA strategy 2020: diagnosis of asthma

2020-07-20T13:17:00+01:00By

This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.

man with asthma

Independent professional body guideline

BTS/SIGN management of difficult asthma guideline

2020-07-10T00:00:00+01:00By

This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.

Pneumonia

NICE guideline

COVID-19 rapid guideline: pneumonia in adults

2020-04-27T00:11:00+01:00By

The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline: severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

Resource hub

  • Inhaler standards and competency document

Educational resources

GSK logo

COPD: LAMA/LABA therapy—Real life case studies

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015

GSK logo

COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014

GSK logo

Why you might want to review patients with COPD receiving a LAMA

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013

GSK logo

COPD: Have you done enough to implement guidelines?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012

GSK logo

Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011